Jun 15 FDA advisers approve COVID-19 vaccine shots for kids under 5 By Lindsey Tanner, Mike Stobbe, Associated Press COVID-19 shots for infants, toddlers and preschoolers in the U.S. have moved a step closer. An advisory panel for the Food and Drug Administration gave a thumbs-up to Moderna's two shots for the littlest kids. Continue reading
Jun 14 FDA advisers back Moderna’s COVID-19 vaccine for older children By Mike Stobbe, Associated Press The Food and Drug Administration's outside experts voted unanimously that Moderna's vaccine is safe and effective enough to give kids ages 6 to 17. If the FDA agrees, it would become the second option for those children, joining Pfizer's vaccine. Continue reading
May 26 WATCH: Infant formula supply will be back to normal in two months, FDA head says By News Desk A shortage of baby formula in the U.S. should be over and supplies will be “beyond normal” within two months, the head of the Food and Drug Administration said on Thursday. Continue reading
May 24 WATCH: FDA officials, baby formula company executives face scrutiny over national shortage By Matthew Perrone, Associated Press The head of the Food and Drug Administration faced bipartisan fury from House lawmakers Wednesday over months of delays investigating problems at the nation's largest baby formula plant that prompted an ongoing shortage. Continue reading
May 20 Watch 4:39 News Wrap: CDC approves Pfizer COVID vaccine booster shots for children ages 5 to 11 In our news wrap Friday, children in the U.S. ages 5 to 11 began receiving their Pfizer COVID vaccine booster shots after the CDC gave its final approval, a federal judge rules COVID asylum restrictions must continue on the border,… Continue watching
May 19 WATCH: FDA head says baby formula factory could reopen by next week By Matthew Perrone, Associated Press FDA Commissioner Dr. Robert Califf faced a bipartisan grilling from House lawmakers over the baby formula issue that has angered American parents and become a political liability for President Joe Biden. Continue reading
May 16 FDA, Abbott reach agreement to reopen baby formula plant By Zeke Miller, Matthew Perrone, Associated Press Infant formula maker Abbott says it's reached an agreement with U.S. health officials to restart production at its largest domestic factory, a key step toward easing a nationwide shortage. Continue reading
May 05 FDA restricts Johnson & Johnson’s COVID-19 vaccine due to blood clot risk By Matthew Perrone, Lauran Neergaard, Associated Press The Food and Drug Administration said Thursday the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J's vaccine. Continue reading
May 03 Biogen to replace CEO after Alzheimer’s drug flops By Matthew Perrone, Tom Murphy, Associated Press Biogen will replace its CEO and largely abandon marketing of its controversial Alzheimer's drug Aduhelm less than a year after the medication's launch triggered a backlash from experts, doctors and insurers. Continue reading
Apr 29 FDA meeting in June to consider COVID vaccines for youngest American children By Geoff Mulvihill, Associated Press The FDA said Friday it plans to convene its outside panel of vaccine experts on June 8, 21 and 22 to review applications from Moderna and Pfizer for vaccines in tots and babies. Continue reading